Get started
Author

Eyad Al‐Hattab

Observed names: E. Al-Hattab, Eyad Al-Hattab, Eyad S. Al-Hattab
OpenAlex ID: A5089901959
Short- and Long-Term Risk Stratification in Acute Coronary Syndromes
2006 · Cynthia M. Westerhout, Yuling Fu, et al. · Journal of the American College of Cardiology · 82
Future Perspectives and Challenges with CDK4/6 Inhibitors in Hormone Receptor–Positive Metastatic Breast Cancer
2020 · Soley Bayraktar, Sameer Batoo, et al. · Future Oncology · 9
Bortezomib and daratumumab in refractory autoimmune hemolytic anemia
2023 · John McGlothlin, Jithma Abeykoon, et al. · American Journal of Hematology · 8
PDF
Recent advances and optimal management of human epidermal growth factor receptor-2-positive early-stage breast cancer
2019 · Soley Bayraktar, Sameer Batoo, et al. · Journal of Carcinogenesis · 6
Patient Understanding of Chemotherapy and Goals of Care as Provided by Different Care Team Members
2023 · Shanzay Suhail, Sandeep Basu, et al. · Journal of Cancer Education · 4
PDF
Bringing Hematological Malignancy Clinical Trials to Patients: Mayo Clinic LLS Impact Experience
2024 · Jamie Johnston, Katie J. Doane, et al. · Blood · 2
PDF
Bortezomib and/or Daratumumab for Treatment of Refractory Autoimmune Hemolytic Anemia
2022 · John McGlothlin, Jithma P. Abeykoon, et al. · Blood · 1
Abstract PS4-03-10: Assessing the impact of real-time serial circulating tumor cell results on the management of patients with metastatic breast cancer
2026 · K. V. Giridhar, D. Zahrieh, et al. · Clinical Cancer Research
Abstract P3-07-29: ACT-MBC: A Prospective Observational Impact Study of Circulating Tumor Cells in Metastatic Breast Cancer
2025 · Karthik Giridhar, Amrit Singh, et al. · Clinical Cancer Research
Works count: 9
Citation count: 112
H-index: 4
I10-index: 1
Year
Topic
Type